HIF1A and Sepsis: Studies have shown that exosomes released from bone marrow mesenchymal stem cells (BMSCs) can reduce macrophage glycolysis by inhibiting HIF-1α, thereby attenuating sepsis-inducing lung injury (Deng et al., 2020).